# Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma

> **NCT00041210** · PHASE3 · UNKNOWN · sponsor: **Mount Vernon Cancer Centre at Mount Vernon Hospital** · enrollment: 850 (estimated)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** bleomycin sulfate
- **DRUG:** ABVD regimen
- **DRUG:** Stanford V regimen
- **DRUG:** dacarbazine
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide
- **DRUG:** mechlorethamine hydrochloride
- **DRUG:** prednisone
- **DRUG:** vinblastine sulfate
- **DRUG:** vincristine sulfate
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00041210
- **Lead sponsor:** Mount Vernon Cancer Centre at Mount Vernon Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2001-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 850 (ESTIMATED)
- **Last updated:** 2013-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00041210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00041210, "Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00041210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*